GPX4 and metabolic dysfunction-associated steatotic liver disease: Dehydroabietic acid promotes the expression of GSH and GPX4, reduces ROS accumulation, reduces hepatic lipid peroxidation, inhibits hepatic ferroptosis, and improves NAFLD (Gao et al., 2021).